4[3]Mailloux LU,Bellucci AG,Wilkes BM.Mortality in dialysis patients:anal-ysis of the causes of death[J].Am J Kidney Dis,1991,18(3):326-335.
5[2]Leber HW,Wizemann V,Goubeaud G,et al,Simultaneous hemofiltration/hemodialysis:an effective ahernative to hemofiltration and conventional hemodialysis in the treatment of uremic patients[J].Clin Nephrol,1978,9(3):115-121.
3Ronco C,Tetta C,Mariano F,et al.Interpreting the mechanisms of continuous renal replacement therapy in sepsis:the peak concentration hypothesis[J].Artif Organs,2003,27(9):792-801.
4Yamada S,Inoue K,Yakabe K,et al.High mobility group protein 1(HMGB-1)quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2[J].Clin Chem,2003,49(9):1 535-1 537.
5Pisetsky DS,Jiang W.Role of Toll-like receptors in HMGB-1 release from macrophages[J].Ann N Y Acad Sci,2007,1109(1):58-65.
6Fossati S,Chiarugi A.Relevance of high-mobility group protein box 1 to neurodegeneration[J].Int Rev Neurobiol,2007,82(1):137-148.
7Ulloa L,Ochani M,Yang H,et al.Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation[J].Proc Natl Acad Sci,2002,99(19):12 351-12 356.
9Mantell LL,Parrish WR,Ulloa L.Hmgb-1 as a therapeutic target for infectious and inflammatory disorders[J].Shock,2006,25(1):4-11.
10Sundén-Cullberg J,Norrby-Teglund A,Rouhiainen A,et al.Persistent elevation of high mobility group box-1 protein(HMGB-1)in patients with severe sepsis and septic shock[J].Crit Care Med,2005,33(3):564-573.
